/People

Chris Carpenter

Investor

Partner at Sofinnova Ventures

Cambridge, Massachusetts, United States

Find your path to Chris

Sign up to see every warm intro you have to Chris

  • Paths you didn't know you had: your email and LinkedIn already hold routes to Chris. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

About

Chris Carpenter is an oncology physician-scientist with over two decades of clinical and laboratory experience who joined Sofinnova in 2022, focusing on clinical-stage product companies in oncology, rare diseases, and specialty therapeutics. He previously served as Chief Medical Officer at CatamaranBio and Rubius Therapeutics, and led cancer epigenetics at GlaxoSmithKline as well as drug development work at Merck. He holds a B.S. from Stanford University and M.D. and Ph.D. degrees from the University of Southern California, and is board certified in internal medicine and medical oncology.

Contact· self-published, not guessed

Invests in

Biotech

Deals · 1

Atsena Therapeutics, Inc.Board seat

via Sofinnova Ventures · filed Apr 2025 · $150M raise

Attribution from SEC filings, press coverage, and firm rosters.

Other disclosed investments

Board seats

AlkeusAtsenaCapstan

Sources: the firm's website · SEC Form D filings.

Colleagues at Sofinnova Ventures

Frequently asked questions

Who is Chris Carpenter?
Chris Carpenter is an oncology physician-scientist with over two decades of clinical and laboratory experience who joined Sofinnova in 2022, focusing on clinical-stage product companies in oncology, rare diseases, and specialty therapeutics. He previously served as Chief Medical Officer at CatamaranBio and Rubius Therapeutics, and led cancer epigenetics at GlaxoSmithKline as well as drug development work at Merck. He holds a B.S. from Stanford University and M.D. and Ph.D. degrees from the University of Southern California, and is board certified in internal medicine and medical oncology.
Where does Chris Carpenter work?
Chris Carpenter is Partner at Sofinnova Ventures.
What does Chris Carpenter invest in?
Chris Carpenter invests in Biotech.
What boards does Chris Carpenter sit on?
Chris Carpenter holds tracked board seats at Alkeus, Atsena, Atsena Therapeutics, Inc., Capstan.

About this profile. Compiled from public sources — Sofinnova Ventures's own website, regulatory filings and public professional profiles — and summarised by Fundraising Fox; every fact is kept with where it came from. Spotted an error, or would rather not be listed? Email privacy@fundraisingfox.com · How we build profiles · Your rights